X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Abbvie

An investor in AbbVie Inc. has sued the pharmaceutical company in Delaware Chancery Court to investigate an alleged kickback scheme that boosted sales of its popular immunosuppressant Humira and potentially exposed the company to more than $6 billion in legal liability.

This premium content is locked for
Delaware Business Court Insider subscribers only.

*May exclude premium content
Already have an account?
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to groupsales@alm.com to learn more.

Tom McParland

Tom McParland of Delaware Law Weekly can be contacted at 215-557-2485 or at tmcparland@alm.com. Follow him on Twitter @TMcParlandTLI.

More from this author

Structured Settlements and Periodic Payment JudgmentsBook

Structured Settlements and Periodic Payment Judgments is a complete reference work for attorneys,
settlement planners, and insurance and annuity brokers
Get More Information

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.